Materials Healthcare Sector

Aditxt

Market Cap: US$1.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Protagenic Therapeutics

Market Cap: US$1.9m

A biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

ZyVersa Therapeutics

Market Cap: US$1.9m

Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

Restart Life Sciences

Market Cap: CA$2.5m

Through its subsidiaries, operates as a biotechnology company worldwide.

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

ENDRA Life Sciences

Market Cap: US$1.8m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

Blueberries Medical

Market Cap: CA$2.5m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Algernon Pharmaceuticals

Market Cap: CA$2.5m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Quantumzyme

Market Cap: US$1.7m

Operates as a biotransformation company.

American Green

Market Cap: US$1.7m

Operates as a technology company in the medical cannabis industry in the United States.

CBD Life Sciences

Market Cap: US$1.7m

Engages in the development and marketing a line of cannabidiol based organic products.

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

RespireRx Pharmaceuticals

Market Cap: US$1.7m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Ocean Biomedical

Market Cap: US$1.7m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

City View Green Holdings

Market Cap: CA$2.3m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

SOHM

Market Cap: US$1.6m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

Pangenomic Health

Market Cap: CA$2.2m

Operates as a precision health company.

United American Healthcare

Market Cap: US$1.6m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

Imagion Biosystems

Market Cap: AU$2.4m

Provides medical imaging technologies using magnetic resonance.

Osteopore

Market Cap: AU$2.4m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

Allied

Market Cap: US$1.5m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

Bio-Path Holdings

Market Cap: US$1.5m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Kaya Holdings

Market Cap: US$1.5m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States.

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.